Ionis Pharmaceuticals (IONS) Profit After Tax (2009 - 2026)

Ionis Pharmaceuticals' Profit After Tax history runs 18 years deep, the most recent figure standing at -$92.5 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 37.03% year-over-year to -$92.5 million; the TTM figure through Mar 2026 stood at -$327.0 million (up 28.61% YoY), while the FY2025 annual figure was -$381.4 million, up 15.97% from the prior year.
• Profit After Tax was -$92.5 million for Q1 2026 at Ionis Pharmaceuticals, up from -$229.4 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $123.6 million in Q2 2025 to a low of -$229.4 million in Q4 2025.
• Historically, Profit After Tax has averaged -$92.0 million across 5 years, with a median of -$104.3 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax tumbled 1026.51% in 2024, then jumped 286.45% in 2025.
• A 5-year view of Profit After Tax shows it stood at -$52.4 million in 2022, then jumped by 82.33% to -$9.3 million in 2023, then sank by 1026.51% to -$104.3 million in 2024, then sank by 119.83% to -$229.4 million in 2025, then jumped by 59.66% to -$92.5 million in 2026.
• The last three Profit After Tax figures came in at -$92.5 million (Q1 2026), -$229.4 million (Q4 2025), and -$128.6 million (Q3 2025), per Business Quant data.